Metastatic castration-resistant prostate adenocarcinoma

Clinical trials for Metastatic castration-resistant prostate adenocarcinoma explained in plain language.

Never miss a new study

Get alerted when new Metastatic castration-resistant prostate adenocarcinoma trials appear

Sign up with your email to follow new studies for Metastatic castration-resistant prostate adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

Can engineered immune cells take down advanced prostate cancer?

Cure Not yet recruiting

This trial tests a new type of cell therapy for men with metastatic castration-resistant prostate cancer, a form of the disease that has spread and no longer responds to standard hormone therapy. The treatment uses the patient's own immune cells, called T cells, which are modifie…

Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA

Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Cure

Last updated Sep 06, 2026 00:00 UTC

Metastatic castration-resistant prostate adenocarcinoma

Get alerted when new Metastatic castration-resistant prostate adenocarcinoma trials appear

Can engineered immune cells take down advanced prostate cancer?